Jul 22, 2019· Comment from American Pharmacists Association, International Academy of Compounding Pharmacists, and National Community Pharmacists Association· FDA-2018-N-3065-0042
Please find attached a joint comment on behalf of the American Pharmacists Association, the International Academy of Compounding Pharmacists, and the National Community Pharmacists Association. Please contact David Pore at 202.223.8881 or dpore@hslawmail.com with any questions. Thank you